Literature DB >> 4219097

Amantadine.

D Parkes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4219097

Source DB:  PubMed          Journal:  Adv Drug Res        ISSN: 0065-2490


× No keyword cloud information.
  7 in total

1.  Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

Authors:  P Sikiric; I Rotkvic; S Mise; M Petek; R Rucman; S Seiwerth; V Zjacic-Rotkvic; M Duvnjak; V Jagic; E Suchanek
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Herpes zoster and postherpetic neuralgia. Optimal treatment.

Authors:  R W Johnson
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

3.  Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.

Authors:  M Brenner; A Haass; P Jacobi; K Schimrigk
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

4.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Adamantane derivatives: a new class of insulin secretagogues.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

6.  Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting beta-cell line, HIT-T15.

Authors:  F M Ashcroft; A J Kerr; J S Gibson; B A Williams
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 7.  Clinical pharmacokinetics of amantadine hydrochloride.

Authors:  F Y Aoki; D S Sitar
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.